Loading clinical trials...
Loading clinical trials...
A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial Investigating the Safety and Efficacy of C21 in Hospitalised Subjects With COVID-19 Infection Not Requiring Mechanical Ventilation
Conditions
Interventions
C21
Placebo
Locations
9
India
Department of Medicine, Civil Hospital and B J Medical College
Ahmedabad, Gujarat, India
Infectious Disease, Metas Adventist Hospital
Surat, Gujarat, India
Clinical Research Department, Basement, Unity Trauma Centre and ICU (Unity Hospital
Surat, Gujarat, India
First Floor Clinical Research Department Rhythm Heart Institute
Vadodara, Gujarat, India
Internal Medicine S.L. Raheja Hospital
Mumbai, Maharashtra, India
Department of Medicine, Government Medical College and Hospital
Nagpur, Maharashtra, India
Start Date
July 21, 2020
Primary Completion Date
October 13, 2020
Completion Date
October 13, 2020
Last Updated
June 23, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Vicore Pharma AB
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions